The ups and downs of DNA repair biomarkers for PARP inhibitor therapies

作者: XiaoZhe Wang , David T Weaver

DOI:

关键词:

摘要: PARP inhibitors are emerging as a valuable new drug class in the treatment of cancer. Recent discoveries make compelling case for complexity DNA repair biomarker evaluation and underscore need to examine at multiple biomarkers relational manner. This review updates current trends strategies use describes impact many on inhibitor benefit cancer clinic.

参考文章(159)
Lesley Alpert, Ming-Sound Tsao, Jesse Paterson, Moulay A. Alaoui-Jamali, Jean Viallet, Nie Zeng-Rong, Elevated DNA Repair Capacity Is Associated with Intrinsic Resistance of Lung Cancer to Chemotherapy Cancer Research. ,vol. 55, pp. 4760- 4764 ,(1995)
Nicholas Turner, Andrew Tutt, Alan Ashworth, Hallmarks of 'BRCAness' in sporadic cancers Nature Reviews Cancer. ,vol. 4, pp. 814- 819 ,(2004) , 10.1038/NRC1457
E. Pennisi, HUMAN GENOME: A Low Number Wins the GeneSweep Pool Science. ,vol. 300, pp. 1484b- 1484 ,(2003) , 10.1126/SCIENCE.300.5625.1484B
R.C. Benjamin, D.M. Gill, ADP-ribosylation in mammalian cell ghosts. Dependence of poly(ADP-ribose) synthesis on strand breakage in DNA. Journal of Biological Chemistry. ,vol. 255, pp. 10493- 10501 ,(1980) , 10.1016/S0021-9258(19)70490-6
I Bièche, R Lidereau, G de Murcia, Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer. Clinical Cancer Research. ,vol. 2, pp. 1163- 1167 ,(1996)
Paul O Hassa, Michael O Hottiger, The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases Frontiers in Bioscience. ,vol. 13, pp. 3046- 3082 ,(2008) , 10.2741/2909
Josiane Ménissier De Murcia, Michelle Ricoul, Laurence Tartier, Claude Niedergang, Aline Huber, Françoise Dantzer, Valérie Schreiber, Jean‐Christophe Amé, Andrée Dierich, Marianne LeMeur, Laure Sabatier, Pierre Chambon, Gilbert De Murcia, Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse The EMBO Journal. ,vol. 22, pp. 2255- 2263 ,(2003) , 10.1093/EMBOJ/CDG206
Durkacz Bw, Hostomsky Z, Kyle S, Wang Lz, White Aw, Curtin Nj, Delaney Ca, Newell Dr, Calvert Ah, Potentiation of Temozolomide and Topotecan Growth Inhibition and Cytotoxicity by Novel Poly(adenosine Diphosphoribose) Polymerase Inhibitors in a Panel of Human Tumor Cell Lines Clinical Cancer Research. ,vol. 6, pp. 2860- 2867 ,(2000)
Hannele Erkko, Bing Xia, Jenni Nikkilä, Johanna Schleutker, Kirsi Syrjäkoski, Arto Mannermaa, Anne Kallioniemi, Katri Pylkäs, Sanna-Maria Karppinen, Katrin Rapakko, Alexander Miron, Qing Sheng, Guilan Li, Henna Mattila, Daphne W Bell, Daniel A Haber, Mervi Grip, Mervi Reiman, Arja Jukkola-Vuorinen, Aki Mustonen, Juha Kere, Lauri A Aaltonen, Veli-Matti Kosma, Vesa Kataja, Ylermi Soini, Ronny I Drapkin, David M Livingston, Robert Winqvist, None, A recurrent mutation in PALB2 in Finnish cancer families Nature. ,vol. 446, pp. 316- 319 ,(2007) , 10.1038/NATURE05609